Moderna and Merck & Co. have developed a cancer vaccine that cuts the risk of death or recurrence of most deadly skin cancer by 44 percent compared to Merck's Keytruda on its own, according to researchers. 

Share:
More In Science
New Animation of Mars
Scientists at the European Space Agency have created an animation showing Mars that's been strung together from photos of a desert canyon on the planet.
New Study Researching 3D Mammograms
A new clinical trial is looking for tens of thousands of participants to research whether 3D mammograms can provide better, more accurate results.
Load More